Marinus Pharmaceuticals reported $95.06M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 564.84M 16.77M
Adamas Pharmaceuticals ADMS:US -4033000 9.97M
ALKERMES ALKS:US $ 1097.9M 46.75M
Amgen AMGN:US $ 8247M 1087M
Aptinyx Inc APTX:US $ 130.76M 18.18M
Arena Pharmaceuticals ARNA:US $ 971.08M 114.91M
Biogen BIIB:US $ 10751.9M 69.7M
Eisai 4523:JP Y 722552M 19369M
Enanta Pharmaceuticals ENTA:US $ 417.85M 18.18M
Esperion Therapeutics ESPR:US $ -304310000 34.92M
Gilead Sciences GILD:US $ 19710M 758M
Intercept Pharmaceuticals ICPT:US $ -203.2M 3.2M
Intra Cellular Therapies ITCI:US $ 553.59M 58.56M
Marinus Pharmaceuticals MRNS:US $ 95.06M 20.27M
Minerva Neurosciences NERV:US $ 36.17M 9.2M
Neurocrine Biosciences NBIX:US $ 1279.2M 73.6M
Ptc Therapeutics PTCT:US $ 196.58M 96M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Sarepta Therapeutics SRPT:US $ 485.11M 50.34M
Supernus Pharmaceuticals SUPN:US $ 785.58M 31.14M
Vertex Pharmaceuticals VRTX:US $ 9196.4M 216.14M
YTE INCY:US $ 2935.86M 208.02M
Zogenix ZGNX:US $ 272.86M 48.42M